Published in Br J Ophthalmol on November 01, 2006
Central retinal vein occlusion in a patient with retinal vasculitis and Crohn's disease. Case Rep Ophthalmol Med (2014) 0.75
Sudden cardiac death caused by coronary vasculitis. Virchows Arch (2012) 0.75
The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol (2001) 2.33
Retinal vasculitis in Crohn's disease. Am J Ophthalmol (1987) 1.36
Crohn's disease and retinal vascular disease. Am J Ophthalmol (1990) 1.33
Unilateral retinal vasculitis, branch retinal artery occlusion and subsequent retinal neovascularization in Crohn's disease. Int Ophthalmol (2001) 1.03
Retinal vasculitis revealed by fluorescein angiography in patients with inflammatory bowel disease. Jpn J Ophthalmol (1999) 0.94
Neovascular glaucoma as a complication of retinal vasculitis in Crohn disease. Am J Ophthalmol (2000) 0.86
Axillary artery occlusion as a presenting feature of Crohn's disease. Postgrad Med J (1989) 0.84
[Occlusion of the ophthalmic artery in Crohn disease]. Klin Monbl Augenheilkd (1994) 0.83
The pathogenesis of Crohn's disease. J Gastroenterol (1994) 0.82
Retinal vasculitis associated with Crohn's disease. Postgrad Med J (1995) 0.82
Production and elimination of disruptive classroom behavior by systematically varying teacher's behavior. J Appl Behav Anal (1968) 19.85
EULAR recommendations for the management of Behçet disease. Ann Rheum Dis (2008) 3.37
Laboratory diagnosis of cryptosporidiosis. J Clin Pathol (1985) 2.90
Chronic relapsing inflammatory optic neuropathy (CRION). Brain (2003) 2.83
Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study. Ophthalmology (2001) 2.61
Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis. Pharmacogenomics J (2007) 2.17
Role of gamma delta T cells in pathogenesis and diagnosis of Behcet's disease. Lancet (1996) 2.12
The pharmacogenetics of chemical carcinogenesis. Pharmacogenetics (1992) 2.12
Behçet's disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens (1999) 2.02
Phospholipase D1 is an effector of Rheb in the mTOR pathway. Proc Natl Acad Sci U S A (2008) 1.97
Systemic corticosteroid therapy--side effects and their management. Br J Ophthalmol (1998) 1.81
Obligation to the least well off in setting mental health service priorities: a consensus statement. Psychiatr Serv (1998) 1.76
Comparison between optical coherence tomography and fundus fluorescein angiography for the detection of cystoid macular edema in patients with uveitis. Ophthalmology (2000) 1.75
Self-testing for falciparum malaria with antigen-capture cards by travelers with symptoms of malaria. Am J Trop Med Hyg (2001) 1.73
Early Neurodegeneration after Hypoxia-Ischemia in Neonatal Rat Is Necrosis while Delayed Neuronal Death Is Apoptosis. Neurobiol Dis (2001) 1.72
Questioning questionnaires. Eye (Lond) (2001) 1.58
Relationship of diabetic microvascular complications to outcome in panretinal photocoagulation treatment of proliferative diabetic retinopathy. Eye (Lond) (1997) 1.58
Glutamine stimulates prostaglandin-sensitive Na(+)-H+ exchange in experimental porcine cryptosporidiosis. Gastroenterology (1994) 1.57
Cytokines in human intraocular inflammation. Curr Eye Res (1992) 1.44
Incidence of symptomatic toxoplasma eye disease: aetiology and public health implications. Epidemiol Infect (1999) 1.42
The challenge of Pneumocystis carinii culture. J Eukaryot Microbiol (1993) 1.42
Intraocular tuberculosis. Eye (Lond) (1990) 1.42
Ocular changes in limited forms of Wegener's granulomatosis. Br J Ophthalmol (1981) 1.39
Radioiodine and Graves' ophthalmopathy reconsidered. Nucl Med Commun (2001) 1.39
The ocular complications of HIV and AIDS. Int J STD AIDS (1997) 1.38
The mitochondrial genome of Xiphinema americanum sensu stricto (Nematoda: Enoplea): considerable economization in the length and structural features of encoded genes. J Mol Evol (2005) 1.38
Comparative ability of various prescription and over-the-counter topical antifungal drug products to inhibit the growth of C. albicans. Adv Wound Care (1994) 1.38
Is ocular toxoplasmosis caused by prenatal or postnatal infection? Br J Ophthalmol (2000) 1.36
Management of Behçet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behçet disease. Ann Rheum Dis (2008) 1.32
Behçet's disease: from Hippocrates to the third millennium. Br J Ophthalmol (2003) 1.30
Genetic and metabolic criteria for the assignment of debrisoquine 4-hydroxylation (cytochrome P4502D6) phenotypes. Pharmacogenetics (1991) 1.27
Role of cytokines in the pathogenesis of posterior capsule opacification. Br J Ophthalmol (2000) 1.26
External ocular infections due to methicillin-resistant Staphylococcus aureus (MRSA). Eye (Lond) (2005) 1.25
Molecular genotyping to predict debrisoquine hydroxylation phenotype. Lancet (1990) 1.25
Genetic dissection of cell growth arrest functions mediated by the Epstein-Barr virus lytic gene product, Zta. J Virol (1999) 1.24
Presentation and outcome of 1107 cases of schistosomiasis from Africa diagnosed in a non-endemic country. Trans R Soc Trop Med Hyg (2000) 1.24
Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions. Ann Neurol (1993) 1.20
Electrophysiological characterisation and monitoring in the management of birdshot chorioretinopathy. Br J Ophthalmol (2005) 1.18
Rapid deformation of "passive" polymorphonuclear leukocytes: the effects of pentoxifylline. J Cell Physiol (1989) 1.17
Use of rapid diagnostic tests for diagnosis of malaria in the UK. J Clin Pathol (2006) 1.17
Blood compartmental metabolism of docosahexaenoic acid (DHA) in humans after ingestion of a single dose of [(13)C]DHA in phosphatidylcholine. J Lipid Res (1999) 1.15
Late onset Leber's optic neuropathy: a case confused with ischaemic optic neuropathy. Br J Ophthalmol (1992) 1.14
Choroidal hypoperfusion in acute posterior multifocal placoid pigment epitheliopathy. An indocyanine green angiography study. Ophthalmology (1995) 1.13
A point prevalence study of 150 patients with idiopathic retinal vasculitis: 1. Diagnostic value of ophthalmological features. Br J Ophthalmol (1989) 1.12
Visual loss and falls: a review. Eye (Lond) (2010) 1.11
Relationship between genotype for the cytochrome P450 CYP2D6 and susceptibility to ankylosing spondylitis and rheumatoid arthritis. Ann Rheum Dis (1996) 1.11
HLA and tumour necrosis factor (TNF) polymorphisms in ocular Behçet's disease. Tissue Antigens (1999) 1.10
Incidence of acute symptomatic toxoplasma retinochoroiditis in south London according to country of birth. BMJ (1995) 1.09
Cyclosporin A in the treatment of posterior uveitis. Trans Ophthalmol Soc U K (1985) 1.08
Surgical treatment of superior bullous rhegmatogenous retinal detachments. Br J Ophthalmol (1985) 1.08
Optic neuropathy in sarcoidosis. J Neurol Neurosurg Psychiatry (1986) 1.07
Successful medical therapy of Acanthamoeba keratitis with topical chlorhexidine and propamidine. Eye (Lond) (1996) 1.07
Factor V Leiden mutation is associated with ocular involvement in Behçet disease. Am J Ophthalmol (1999) 1.06
Falciparum malaria in malaria-naive travellers and African visitors. QJM (2004) 1.05
Metastatic choriocarcinoma presenting as multiple intracerebral haemorrhages: the role of imaging in the elucidation of the pathology. J Neurol Neurosurg Psychiatry (1998) 1.04
Genotyping for polymorphisms in xenobiotic metabolism as a predictor of disease susceptibility. Environ Health Perspect (1994) 1.02
A British ophthalmological surveillance unit. British Ophthalmological Surveillance Unit Steering Committee. Br J Ophthalmol (1997) 1.01
Identification of possible artifacts in the association of official analytical chemists sporicidal test. Appl Environ Microbiol (1995) 1.01
Utility of history, examination and laboratory tests in screening those returning to Europe from the tropics for parasitic infection. Trop Med Int Health (2000) 0.99
Streptococcus anginosus-associated endogenous endophthalmitis mimicking fungal endophthalmitis. J Clin Microbiol (2005) 0.98
Acute retinal necrosis in children caused by herpes simplex virus. Retina (2001) 0.98
Recognition of B-cell epitopes of the 65 kDa HSP in Behçet's disease. Scand J Immunol (1996) 0.98
Sinusitis in HIV-infected patients: a clinical and radiographic review. Am J Med (1992) 0.98
Platelet expression of tumour necrosis factor-alpha (TNF-alpha), TNF receptors and intercellular adhesion molecule-1 (ICAM-1) in patients with proliferative diabetic retinopathy. Clin Exp Immunol (1999) 0.98
Distinct cellular factors regulate the c-myb promoter through its E2F element. Mol Cell Biol (1999) 0.98
Cyclosporin A in the treatment of severe Behçet's uveitis. Br J Rheumatol (1987) 0.97
Plasma cleaning of dental instruments. J Hosp Infect (2004) 0.97
Ocular neuromyotonia. Br J Ophthalmol (1996) 0.96
Cerebral and retinal vascular changes in systemic lupus erythematosus. Ophthalmology (1985) 0.96
Experimental posterior uveitis. I: A clinical, angiographic, and pathological study. Br J Ophthalmol (1987) 0.96
Evidence for control of tumour necrosis factor-alpha (TNF-alpha) activity by TNF receptors in patients with proliferative diabetic retinopathy. Clin Exp Immunol (1999) 0.95
Experimental mucosal induction of uveitis with the 60-kDa heat shock protein-derived peptide 336-351. Eur J Immunol (1998) 0.95
Resolution of calcific band keratopathy after lowering elevated serum calcium in a patient with sarcoidosis. Br J Ophthalmol (1995) 0.95
Canalicular infection caused by Actinomyces. Eye (Lond) (1993) 0.95
Growth rate characteristics of acoustic neuromas associated with neurofibromatosis type 2. Laryngoscope (1996) 0.95
Investigation of tropical eosinophilia; assessing a strategy based on geographical area. J Infect (2003) 0.95
Taurine: an essential nutrient for the cat. J Nutr (1978) 0.94
Anterior visual system involvement in non-Hodgkin's lymphoma. Br J Ophthalmol (1993) 0.94
Ptosis and supranuclear downgaze paralysis. Neurology (1989) 0.94
Retinal vasculitis. Postgrad Med J (1988) 0.93
Soluble intercellular adhesion molecule-1 (sICAM-1) as a marker of disease relapse in idiopathic uveoretinitis. Clin Exp Immunol (1994) 0.93
Human antiretinal antibodies in toxoplasma retinochoroiditis. Br J Ophthalmol (1998) 0.93
Pharmacological and electrophysiological characterization of nine, single nucleotide polymorphisms of the hERG-encoded potassium channel. Br J Pharmacol (2009) 0.93
MIC-A allele profiles and HLA class I associations in Behçet's disease. Immunogenetics (1999) 0.93
Ladies with Leber's hereditary optic neuropathy: an atypical disease. Eur J Ophthalmol (2003) 0.93
Clinically achievable plasma deferoxamine concentrations are therapeutic in a rat model of Pneumocystis carinii pneumonia. Antimicrob Agents Chemother (1995) 0.91
Serpiginous choroiditis: an unusual presentation of ocular sarcoidosis. Br J Ophthalmol (1994) 0.91
A community-based study of adverse pregnancy outcomes near a large hazardous waste landfill in California. Toxicol Ind Health (1997) 0.91
Role of the enteric nervous system in piglet cryptosporidiosis. J Pharmacol Exp Ther (1996) 0.91
Tuberculosis presenting as retinal vasculitis. J R Soc Med (1988) 0.91
Systematic review of ethnic variation in the phenotype of Behcet's disease. Scand J Rheumatol (2007) 0.90
The efficacy of systemic corticosteroids in sight-threatening retinal vasculitis. Eye (Lond) (1994) 0.90